ORAL C5A RECEPTOR ANTAGONIST CCX168 IN A PHASE 2 CLINICAL TRIAL IN ANCA-ASSOCIATED RENAL VASCULITIS

被引:0
|
作者
Bekker, Pirow [1 ]
Potarca, Antonia [1 ]
Dairaghi, Daniel [1 ]
Miao, Shichang [1 ]
Powers, Jay P. [1 ]
Jaen, Juan C. [1 ]
Schall, Thomas J. [1 ]
机构
[1] Chemocentryx Inc, Mountain View, CA USA
关键词
D O I
暂无
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
引用
收藏
页码:419 / 420
页数:2
相关论文
共 41 条
  • [41] Effect Of Qaw039, An Oral Prostaglandin D2 Receptor (dp2/crth2) Antagonist, Upon Sputum And Bronchial Eosinophilic Inflammation And Clinical Outcomes In Treatment-Resistant Asthma: A Phase 2a Randomized Placebo-Controlled Trial
    Berair, R.
    Gonem, S.
    Singapuri, A.
    Hartley, R.
    Laurencin, M.
    Bacher, G.
    Holzhauer, B.
    Bourne, M.
    Mistry, V.
    Pavord, I.
    Mansur, A. H.
    Wardlaw, A.
    Siddiqui, S.
    Kay, R.
    Brightling, C. E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191